戻る Agenda
Session 5 Track 2: Labeling Across Borders, Audiences, and Technologies
Session Chair(s)
Dan Benau, PhD
Director, Biomedical Writing Programs
University of the Sciences, United States
This session will provide an overview of labeling for prescription medicines and efforts to expand its audience to patients as well as prescribers. It will highlight the global influences and mechanisms in pharmaceutical product labeling, and consider the possible uses of technology.
Learning Objective : At the conclusion of this session, participants should be able to:
- Identify the changing audiences for labeling of prescription medicines
- Discuss the global influences on essential product information
- Evaluate the promise of certain technology for healthcare product labeling
Speaker(s)
Adding the Patient to the Audience for Written Information About Prescription Medicines
Cathleen O'Connell, PhD, MS, RPh
University of the Sciences, Misher College, United States
Assistant Professor
Global Considerations in Pharmaceutical Product Labeling
Cathleen O'Connell, PhD, MS, RPh
University of the Sciences, Misher College, United States
Assistant Professor
Global Considerations in Pharmaceutical Product Labeling
Ameesha D Batheja, PhD, MSc
Janssen Pharmaceuticals, United States
Director, Regional Regulatory Affairs
The Promise of Artificial Intelligence in the Drug Labeling Process
Jaquetta Lee, MS
Merck & Co., Inc., United States
Associate Content Steward